阿布扎比的药物开发:通过政府支持和繁荣的生态系统推进创新
Namir Shaabani1,2, Aleh Ibrahim Saleh2, Mohamed Salem Alameri3
1Attentive Science LTD, Masdar City, Abu Dhabi, UAE.
概括
在阿布扎比,阿布扎比就是阿布扎比.
科学领域:
- 生命科学 生命科学
- 生物技术是生物技术.
- 制药发展 制药发展
背景情况:
- 药物开发面临着包括高成本,监管障碍和低临床试验成功率在内的全球性挑战.
- 生物技术初创企业和新兴市场在获得基础设施,患者群体和资金方面遇到了特别困难.
研究的目的:
- 倡导阿布扎比的生命科学生态系统作为加速新兴市场制药创新的典范.
- 突出阿布扎比的框架如何解决行业瓶,促进可持续药物开发增长.
主要方法:
- 这个视角分析了阿布扎比生命科学生态系统的组成部分.
- 它确定了促进其作为其他地区模式潜力的关键因素.
主要成果:
- 阿布扎比提供政府支持的激励措施,先进的研究基础设施和监管支持.
- 获取区域基因组数据是药物开发的关键资产.
结论:
- 阿布扎比的综合方法为克服药物开发挑战提供了一个可行的框架.
- 这种模式可以被其他新兴市场适应,以促进生命科学领域的创新和增长.
关键词:
药物开发;阿联;阿布扎比相关概念视频
Preclinical Development: Overview
4.8K
Preclinical development consists of a series of tests that ensure the safety and efficacy of a new therapeutic compound before it is tested in humans. There are four main phases to this process. First, safety pharmacology tests are conducted to ensure the drug does not produce any acutely harmful effects. These tests examine parameters such as bronchoconstriction, cardiac dysrhythmias, blood pressure changes, and ataxia. Next, preliminary toxicological testing is performed to determine the...
4.8K
Drug Discovery: Overview
8.8K
Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...
8.8K
Clinical Trials: Overview
3.4K
Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
3.4K
Drug Control Governance: Regulatory Bodies and Their Impact
252
Drug control governance involves the oversight and regulation of pharmaceuticals to ensure their safety and efficacy while preventing illegal drug use and trafficking. Regulatory bodies, including the US Food and Drug Administration (FDA) and the European Union's European Medicines Agency (EMA), play a central role in this process. These agencies evaluate the safety and efficacy of drugs before they can be marketed. They fund clinical trials and assess the benefits and risks associated with...
252
Drug Regulation
1.9K
Drug regulation encompasses the management of drug usage by evaluating its safety and efficacy through assessments conducted by regulatory authorities. Regrettably, the history of drug regulation is marred by several catastrophic events. One such incident is the Elixir Sulfanilamide tragedy, in which the toxic compound diethyl glycol was included in a sweet-tasting medication, leading to numerous fatalities. This event prompted the enactment of the Food, Drug, and Cosmetic Act in 1938. Under...
1.9K
Structure-Activity Relationships and Drug Design
1.1K
Drug design is a dynamic field that involves discovering and developing new medications based on specific biological targets. This process heavily relies on structure-activity relationships (SAR) and quantitative structure-activity relationships (QSAR) to guide the design and optimization of efficient drugs.
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
1.1K


